RAF1 and neoplasm: It has become clear that ATP mimetic inhibitors of RAF drive dimerization of WT BRAF and CRAF, lead to phosphorylation of CRAF on serine 338, potentiate the MEK/ERK pathway and thereby contribute to the observed increase in tumour growth38, 39, 40.